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OutbreakZika virus has only recently gained attention due to recent large outbreaksworldwide. An easy to use nucleic acid
ampliﬁcation test could play an important role in the early detection of the infection and patient management.
Here, we report a rapid and robust isothermal nucleic acid ampliﬁcation assay for the detection of Zika virus.
The method is cost-effective and compatible with portable instrumentation, enabling near patient testing and
ﬁeld use.358-10-426-279
(K.E. Eboigbodin)
This is an open ac© 2016 TheAuthors. PublishedbyElsevier Inc. This is anopenaccess article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Report
The recent Zika virus outbreak sparked renewed research interest in
virus detection (Rubin et al., 2016). There is increasing evidence that
Zika virus increases the risk of microcephaly, a major birth defect, and
Guillain–Barré syndrome in infected individuals (Rubin et al., 2016;
Chang et al., 2016; Driggers et al.). The established transmission route
is via an insect vector, mainly the Aedes aegyptimosquito, while sexual
transmission has been demonstrated (Chang et al., 2016; Zanluca &
dos Santos, 2016). Diagnosis of Zika virus has so far relied on serological
methods which are often time consuming or nucleic acid ampliﬁcation
tests (NAATs) such as real-time reverse transcription polymerase
chain reaction (RT-PCR) (Faye et al., 2008, 2013; Balm et al., 2012).
RT-PCR requires the use of high precision instruments for thermal
cycling reactions and skilled personnel for performing the complex
protocol and data interpretation. Consequently, RT-PCR has been
primarily conﬁned to specialized large central laboratories.
NAATs performed on relatively simple, portable, and low-cost
devices are becoming increasingly desirable as they can be employed
in ﬁeld testing or point-of-care settings, allowing for a rapid response
to outbreaks particularly in low resource settings. Here, we present
an alternative NAAT, the reverse transcription strand invasion
based ampliﬁcation (RT-SIBA) assay for the rapid detection of Zika virus.4.
.
cess article under thRT-SIBA has been previously applied to the rapid detection of DNA (Hoser
et al., 2014; Eboigbodin & Hoser, 2016) and RNA (Eboigbodin et al., 2016)
from pathogens. During RT-SIBA reactions, Zika virus RNA is ﬁrst reverse
transcribed to cDNA followed by ampliﬁcation and detection of cDNA
under isothermal reaction conditions. SIBA relies on a recombinase-coated
single-stranded invasion oligonucleotide (IO) for the separation of a com-
plementary target duplex. This results in the generation of a single-
stranded target template that is bound and extended by target-speciﬁc
primers via DNA polymerase. The repeated cycles of strand separation
and primer extension of the target lead to an exponential ampliﬁcation at
low and constant temperature. The method can be run on relatively low-
cost devices and features low sample preparation, and has the potential
to allow for the early detection of outbreaks, treatment management, and
preventing the spread of the virus. We also compared the performance of
RT-SIBA with real-time PCR for the detection of Zika virus.
Zika virus genome sequences were retrieved from the GenBank se-
quence database and aligned for identiﬁcation of conserved regions.
RT-SIBA and RT-PCR assayswere designed to detect the 5′ conserved re-
gion of the Zika virus genome (sequences and protocol are provided in
the Supplementary material). Both RT-SIBA and RT-PCR reactions
were detected using the intercalating dye Sybr Green 1. The analytical
sensitivities of both the RT-SIBA and RT-PCR Zika virus assays were
established in at least three independent experiments using serial dilu-
tions of in vitro transcribed RNA, and total RNA extracted was from the
Zika virus strain MR766 (a kind gift from Dr. Livia Schrick, Robert Koch
Institute, Germany). The in vitro transcribed RNAwas used at 107 copiese CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. SIBA Zika virus assay. (A) Sensitivity using in vitro transcribed RNA; (B) sensitivity
using Zika virus RNA. The results are expressed in copy number per reaction.
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was used at 103 copies to 10 copies, per reaction. The results
are shown in Fig. 1 and Table 1. The results are expressed in total copy
number per reaction.
Both RT-SIBA and RT-PCR reproducibly detected targets as low as 10
copies of either in vitro transcribed or extracted RNA. The average times
to positive results for both RT-SIBA and RT-PCR Zika reactions are
listed in Table 1. In RT-SIBA, the time to positive results for 1000 copies
of in vitro transcript RNA template was obtained after an average
17 minutes. Conversely, positive results for 1000 copies of in vitro
transcript RNA template by RT-PCR were obtained after an average
68 minutes. RT-SIBA allows for the simultaneous reverse transcription
of Zika virus RNA and ampliﬁcation of cDNA at the same reaction tem-
perature. This allows for the rapid detection of Zika virus RNA within
30 minutes and was signiﬁcantly faster than the RT-PCR method. The
RT-PCR method requires an initial reverse transcription incubation
step of 30minutes at a constant temperature before cDNA ampliﬁcation.
Consequently, the total reaction time for RT-PCRwas approximately 2 h.Table 1
Sensitivity of the Zika virus RT-SIBA assay compared with the RT-PCR assay.*
RT-SIBA RT-PCR
Zika virus transcript
copy number
per reaction
Average time to
positive results (min)
Average time to positive results,
min* (Threshold cycle, Ct)
107 10.3 50.3 (13.8)
106 11.4 54.8 (17.4)
105 12.9 61 (22.4)
104 14.7 64.4 (25.1)
103 17.1 68.4 (28.3)
102 18.5 71.9 (31.1)
101 25.8 74.1 (32.9)
0 ND 74.8 (33.4)
⁎ The detection time for RT-PCR was determined according to the threshold cycle (Ct)
value. This was calculated directly from the One-step PCR program without taking into
account the ramping time required for thermal cycling. ND, not determined; RT-PCR,
real-time reverse transcription polymerase chain reaction; RT-SIBA, reverse transcription
Strand Invasion Based Ampliﬁcation. The results are expressed in copy number per reaction.RT-SIBA did not produce any detectable signals in the absence of a
template, whereas a detectable signal was produced by RT-PCR after
30 threshold cycles (Ct). The Ct values for the no-template controls
(NTC) were similar or overlapped with the Ct values for low copies of
in vitro transcribed Zika virus RNA. This is likely due to primer dimers
as the reactions were performed using an intercalating dye rather
than a target-speciﬁc probe (Chou et al., 1992). The use of target speciﬁc
probes such as Taqman andmolecular beacons eliminates the detection
of primer dimers. The speciﬁcities of both ampliﬁcationmethods for the
detection of Zika virus were established by challenging the reaction
with 103 copies of RNA from yellow fever, dengue 1, West Nile and
Chikungunya virus. The assays were further challenged by the addition
of DNA pooled from 15 different unrelated microorganisms (103 DNA
copies per reaction; see Supplementarymaterial for the list of unrelated
microorganisms). Yellow fever, dengue 1, West Nile, Chikungunya
virus, or any of the 15 different unrelated microorganisms were not
detected by the RT-SIBA and RT-PCR Zika assays. This may indicate
that both the RT-SIBA and RT-PCR assays are speciﬁc for the detection
of Zika virus RNA.
The performance of RT-SIBA in the detection of Zika virus was fur-
ther determined using the commercially available NATtrol Zika Virus
Range Veriﬁcation Panel samples (ZeptoMetrix, Buffalo, NY, USA) that
were developed to mimic clinical specimens with Zika virus infection.
The panel consisted of three Zika virus specimens that differed in their
viral load (high,medium, and low) and a negative specimen. Each spec-
imen was subjected to quick crude lysis by the addition of 10–50 μl of
lysis buffer (2% Triton X-100, 12 mM magnesium acetate), and 2 μl of
this mixture was added to the reaction. The RT-SIBA Zika virus assay
was observed to detect all three Zika virus specimens, with no cross-
reaction with the negative specimen. The average time to positive re-
sults for clinical specimens with high, medium, and low Zika viral
loads was 18, 20, and 22 minutes, respectively (Fig. 2A). This suggests
that RT-SIBA does not require highly puriﬁed RNA for performing the10 20 30 40
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Fig. 2. NATtrol Zika virus validation panel results. (A) RT-SIBA reaction performed using
the real-time PCR device, Agilent MX3005P, and (B) parallel reactions performed using a
portable ﬂuorescence detection device, Orion GenRead, that is suitable for point-of-care
or ﬁeld applications. The number of viral particles per sample was not reported by the
manufacturer. The ct ranges for NaTtrol high, medium and low samples were 22–25,
25–28 and 28–31 respectively.
371K.E. Eboigbodin et al. / Diagnostic Microbiology and Infectious Disease 86 (2016) 369–371reactions. Similar reactions were performed on a battery-operated por-
table ﬂuorescence detection system (Orion GenRead, Orion Diagnostica
Oy, Espoo, Finland), since RT-SIBA is performed at a low and constant
temperature (Fig. 2B). The portable ﬂuorescence detection system
was found to perform similarly to the qPCRdevice, highlighting the suit-
ability of RT-SIBA for ﬁeld applications. Despite the rapid detection
displayed by RT-SIBA Zika virus assay, the assay still needs to be fully
validated for direct detection of clinical specimens infected with Zika
virus. The rapid detection and high analytical sensitivity displayed by
RT-SIBA for the detection of Zika virus, as well as tolerance to sample-
derived inhibition, demonstrate that the method may be a powerful
molecular diagnostic tool for the detection of Zika virus. Since the
method can be run on portable and relatively low-cost devices, it may
be applied in the rapid response to outbreaks.
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